News

Eli Lilly has reported positive results for its experimental drug mirikizumab in a late-stage study

In the current market scenario, investors in generic pharmaceutical companies are advised to adopt a

Access Healthcare, a global leader in revenue cycle management (RCM) and healthcare services, has announced